Willow Biosciences Inc T.WLLW

Alternate Symbol(s): CANSF

Willow Biosciences Inc. is a Canada-based biotechnology company. The Company develops and produces precision fermented functional ingredients for the health and wellness, food and beverage and personal care markets. Its FutureGrown biotechnology platform allows production with sustainability at its core. Its commercial product, Cannabigerol CBG, which is a cannabinoid that has anti-microbial, anti-inflammatory, and antioxidant properties. It also offers BioOxi, a bio-oxidation technology platform. By leveraging BioOxi, commercial partners can revolutionize manufacturing of oxygenated and hydroxylated functional ingredients, such as steroids, polyphenols, oxyterpenes and certain other targeted ingredients produced from such methods. It is also developing BioOxi-based process for production of the generic active pharmaceutical ingredient (API), hydrocortisone, and its derivatives. Its other pipeline products include Ursodeoxycholic acid (UCAC), Astaxanthin, B-carotene and others.

TSX:WLLW - Post by User

Willow Biosciences Inc

<< Previous

Bullboard Posts

Next >>

Post by Betteryear2on May 23, 2023 7:07am

262 Views

Post# 35459760

KALSEC AND WILLOW BIOSCIENCES TO DEVELOP NOVEL ENZYME

Rapid success of first collaboration leads to partnership on high-value specialty ingredient

Enzyme development expected to enable commercial-scale production in 2024

KALAMAZOO, Mich. and MOUNTAIN VIEW, Calif., May 23, 2023 /PRNewswire/ - Willow Biosciences Inc. ("Willow") (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on revolutionizing industrial manufacturing of pure, consistent and sustainable functional ingredients and Kalsec® Inc. ("Kalsec"), a leading global producer of natural taste and sensory, food protection, colors and advanced hops ingredients for the food and beverage industry, announce entry into a follow-on Master Services Agreement (the "MSA") to develop an enzyme used in biocatalytic production of a new, advanced ingredient used in natural beverage applications. This marks the second collaborative development program the two parties have engaged on following the announcement of an MSA on November 8, 2022 for which Willow has already successfully achieved development goals in short order.

KALSEC AND WILLOW BIOSCIENCES TO DEVELOP NOVEL ENZYME FOR PRODUCTION OF AN ADVANCED BEVERAGE INGREDIENT (prnewswire.com)